首页|期刊导航|四川中医|大黄牡丹汤对穿孔性阑尾炎术后患者炎症因子的干预分析

大黄牡丹汤对穿孔性阑尾炎术后患者炎症因子的干预分析OA

Analysis of intervention of Dahuang Mudan Decoction on inflammatory factors in patients with perforated appendicitis after operation

中文摘要英文摘要

目的 基于倾向性评分匹配法分析穿孔性阑尾炎(PA)患者术后加用大黄牡丹汤对炎症因子水平的影响.方法 回顾性选取 2020 年 1 月~2024 年 12 月盐城市第三人民医院及青海同德县人民医院收治的 312 例穿孔性阑尾炎患者作为研究对象,对照组术后常规抗炎治疗(253 例),观察组术后常规抗炎基础上加用大黄牡丹汤(59例).采用倾向性匹配法平衡组间混杂因素,以 1∶1 比例进行匹配.对比匹配后两组以下指标:基线资料;治疗效果;证候积分;手术相关指标;炎症因子指标[肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、IL-8、IL-10、IL-12P70];胃肠功能恢复指标;术后并发症情况.结果 采用倾向性评分匹配法后观察组56例与对照组56例匹配成功,治疗后 5 天总有效率观察组(98.21%)优于对照组(87.50%),差异有统计学意义(P<0.05);治疗后 5 天与对照组比较,观察组有着更低的中医证候积分与TNF-α、IL-6、IL-8 水平(P<0.05);而两组IL-10、IL-12P70 较治疗前均有不同程度提高(P<0.05),但组间比较没有统计学意义(P>0.05).在肠鸣音恢复时间、首次排气时间、首次排便时间和术后住院时间上,相比对照组,观察组均更短(P<0.05).在术后并发症发生率上,两组无明显差异(P>0.05).结论 针对PA患者,术后给予大黄牡丹汤治疗,效果与安全性皆理想,可使其炎症反应得到显著减轻,同时还有助于其中医症状的明显改善,缩短住院时间且促进术后恢复,在基层医院能够广泛普及,故而具有推广价值.

Objective To analyze the effect of postoperative adjunctive therapy with Dahuang Mudan Decoction on inflammatory cytokine levels in patients with perforated appendicitis(PA)using propensity score matching(PSM).Methods A retrospective study included 312 PA patients admitted to Yancheng Third People's Hospital and Qinghai Tongde County People's Hospital between January 2020 and December 2024.Among them,253 patients received conventional postoperative anti-inflammatory treatment(control group),and 59 patients received additional Dahuang Mudan Decoction alongside conventional anti-inflammatory therapy(observation group).Propensity score matching(PSM)was applied to balance confounding factors between groups with a 1∶1 matching ratio.After matching,the following outcomes were compared:baseline characteristics;treatment efficacy;TCM syndrome scores;surgery-related indicators;inflammatory cytokine levels[tumor necrosis factor-α(TNF-α),interleukin-6(IL-6),IL-8,IL-10,IL-12P70];gastrointestinal function recovery parameters;incidence of postoperative complications.Results After PSM,56 patients in the observation group were successfully matched with 56 in the control group.On day 5 post-treatment,the total effective rate was significantly higher in the observation group(98.21%)than in the control group(87.50%)(P<0.05).The observation group also showed significantly lower TCM syndrome scores and lower levels of TNF-α,IL-6,and IL-8(P<0.05).Levels of IL-10 and IL-12P70 increased from baseline in both groups(P<0.05),but the intergroup difference was not statistically significant(P>0.05).Compared with the control group,the observation group had significantly shorter time to bowel sound recovery,first flatus,first defecation,and postoperative hospital stay(P<0.05).There was no significant difference in the incidence of postoperative complications between the two groups(P>0.05).Conclusion Postoperative administration of Dahuang Mudan Decoction in PA patients demonstrates favorable efficacy and safety.It significantly reduces inflammatory response,improves TCM symptoms,shortens hospital stay,and promotes postoperative recovery.Its applicability in primary hospitals suggests significant value for widespread adoption.

沈加成;张泱;唐晓华;吉建中;陈爱山

南通大学第六附属医院(盐城市第三人民医院)普外科,江苏 盐城 224001青海省同德县人民医院外科,青海 同德 813200盐城市第三人民医院中医科,江苏 盐城 224001青海省同德县人民医院外科,青海 同德 813200||盐城市射阳县中医院中医科,江苏 盐城 224300南通大学第六附属医院(盐城市第三人民医院)普外科,江苏 盐城 224001||青海省同德县人民医院外科,青海 同德 813200

医药卫生

穿孔性阑尾炎大黄牡丹汤证候积分炎症因子倾向性评分匹配法

Perforating appendicitisDahuang Mudanpi DecoctionTCM syndrome scoresInflammatory factorsPropensity score matching(PSM)

《四川中医》 2026 (1)

84-90,7

10.26946/j.cnki.1000-3649.sczy.2506200006

评论